Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Gujarat Themis Biosyn Ltd.
₹389.40
₹385.00
₹407.95
₹225.05
₹479.00
Markets Today
Historical Performance
As of 06-07-2026 03:18, Gujarat Themis Biosyn Ltd. share price today is ₹0, with a change of ₹-396.00 (-100.00%) from the previous close of ₹396. The stock opened at ₹396.45 and traded between ₹385 and ₹407.95, with a total traded volume of 120377 shares. The company has a market capitalization of ₹4205.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹479 and ₹225.05, respectively.
Gujarat Themis Biosyn Ltd. valuation metrics include a P/E ratio of 90.1, and book value of ₹14.60. Profitability indicators show ROE of 16.22% along with a dividend yield of 0.2%. Gujarat Themis Biosyn Ltd. has reported revenue of ₹165.82 Cr and net profit of ₹46.68 Cr.
Gujarat Themis Biosyn Ltd. technical indicators include Day RSI at 54.07, Day MFI at 80.67, Day ADX at 23.77. Additional indicators include Commodity Channel Index (CCI) at 16.3 and Williams %R at -40.45. Momentum indicators show Day MACD at 4.8, Day MACD Signal Line at 5.59, DayATR at 17.62. Rate of Change indicators for Gujarat Themis Biosyn Ltd. include ROC125 at -10.67 and ROC21 at 0.25.
Exponential moving averages include EMA5 at ₹394.7, EMA10 at ₹393.3, EMA12 at ₹392.9, EMA20 at ₹390.7, EMA26 at ₹388.1, EMA50 at ₹375.4, EMA100 at ₹363.1, EMA200 at ₹353.4. Simple moving averages include SMA5 at ₹393.4, SMA10 at ₹392.7, SMA20 at ₹392.7, SMA30 at ₹390.8, SMA50 at ₹380.8, SMA100 at ₹339.2, SMA150 at ₹355, SMA200 at ₹372.6.
Support levels for Gujarat Themis are placed at First Support ₹390.55, Second Support ₹385.10, Third Support ₹379.20. Resistance levels are seen at First Resistance ₹401.90, Second Resistance ₹407.80, Third Resistance ₹413.25. Gujarat Themis Biosyn Ltd. shareholding pattern shows promoter holding at 70.86%, FII holding at 1.8%, DII holding at 0%, public holding at 26.15%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 44.23 | 43.37 | 42.35 | 35.87 | 37.74 |
| Operating Expense | 24.87 | 22.06 | 21.41 | 21.95 | 21.70 |
| Operating Profit | 19.36 | 21.31 | 20.94 | 13.92 | 16.04 |
| Depreciation | 4.04 | 3.89 | 2.96 | 2.03 | 1.23 |
| Interest | 1.91 | 0.96 | 0.04 | 0.04 | 0.07 |
| Tax | 3.45 | 4.41 | 4.50 | 3.06 | 4.09 |
| Net Profit | 10.89 | 12.46 | 14.26 | 9.06 | 12 |
₹389.40
↗ Bullish Moving Average
7
↘ Bearish Moving Average
9
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 | 70.9 |
| FII | 1.4 | 1.9 | 2.5 | 3 | 2 | 1.8 |
| DII | 1.2 | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 |
| Public | 26.6 | 26 | 25.4 | 25 | 26 | 26.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 38.94 K | 76.65 K | 50.80% |
| Week | 54.64 K | 1.01 L | 53.84% |
| 1 Month | 95.1 K | 1.71 L | 55.46% |
| 6 Month | 80.11 K | 2.47 L | 32.46% |
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Expensive Performers (DVM)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Overbought by Money Flow Index (MFI)
Increasing Revenue every quarter for the past 3 quarters
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Sep, 2025 | 0.67 | FINAL | 05 Sep, 2025 | Equity Share |
| 15 Jul, 2024 | 0.25 | FINAL | Equity Share | |
| 22 Feb, 2024 | 0.75 | INTERIM | 22 Feb, 2024 | Equity Share |
| 01 Sep, 2023 | 1 | FINAL | Equity Share | |
| 01 Dec, 2022 | 4.4 | INTERIM | 02 Dec, 2022 | Equity Share |
| 29 Aug, 2022 | 4 | FINAL | Equity Share | |
| 24 Nov, 2021 | 2 | INTERIM | 25 Nov, 2021 | Equity Share |
| 24 Nov, 2021 | 5 | SPECIAL | 25 Nov, 2021 | Equity Share |
| 10 Sep, 2020 | 1.65 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹621.75 | ₹5.79 | ₹160.21 | ₹15.89 | ₹539 | ₹65 |
| % Change | -0.33% | 1.05% | 0.06% | -0.06% | -0.65% | 0.29% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.40 | 42.60 | 30.30 | 26.90 | -107.80 |
| 1 Year Return | 57.81 | 479 | 29.44 | 74.4 | -25.07 | -39.07 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.70
-0.87%
Windlas Biotech Ltd.
₹ 871.95
+1.24%
Vineet Laboratories Ltd.
₹ 33.75
+0.39%
Solara Active Pharma Sciences Ltd.
₹ 575.25
+0.58%
Zim Laboratories Ltd.
₹ 122.01
-2.00%
Medico Remedies Ltd.
₹ 40.00
-1.01%
Dishman Carbogen Amcis Ltd.
₹ 196.97
+4.91%
Lasa Supergenerics Ltd.
₹ 7.49
+0.94%
Advanced Enzyme Technologies Ltd.
₹ 321.00
+2.41%
Bajaj Healthcare Ltd.
₹ 345.00
+0.77%
Ortin Global Ltd.
₹ 16.94
+1.99%
Brooks Laboratories Ltd.
₹ 77.60
+2.23%
RPG Life Sciences Ltd.
₹ 2415.00
+0.89%
Bafna Pharmaceuticals Ltd.
₹ 216.45
-2.00%
Alpa Laboratories Ltd.
₹ 69.39
+0.43%
SMS Pharmaceuticals Ltd.
₹ 424.00
+1.52%
Nectar Lifesciences Ltd.
₹ 11.77
-1.09%
Mangalam Drugs and Organics Ltd.
₹ 28.43
+0.64%
Indoco Remedies Ltd.
₹ 243.10
-0.38%
Ind-Swift Laboratories Ltd.
₹ 214.50
+4.02%
Lincoln Pharmaceuticals Ltd.
₹ 623.95
-0.05%
Panacea Biotec Ltd.
₹ 552.10
+0.70%
Medicamen Biotech Ltd.
₹ 260.10
+1.30%
Themis Medicare Ltd.
₹ 118.99
-0.10%
By signing up I certify terms, conditions & privacy policy